Literature DB >> 12052458

Effect of feeding on bone turnover markers and its impact on biological variability of measurements.

J A Clowes1, R A Hannon, T S Yap, N R Hoyle, A Blumsohn, R Eastell.   

Abstract

Bone turnover markers are subject to day-to-day and within-day variability, which may influence clinical interpretation. We examined the effect of fasting vs. feeding on the concentration and between-day variability of several markers. Twenty healthy premenopausal women were studied on 10 consecutive weekdays. Subjects were studied either in the fasting (no breakfast) or fed (breakfast at 08:00 h) state on alternate days, and were randomized to begin either fasting or fed. Two hour urine collections were obtained each day between 08:00 h and 10:00 h, and blood samples were collected daily at 09:00 h. The N-telopeptide cross-link of type I collagen in urine (uNTX) and serum (sNTX), the C-telopeptide in urine (uCTX) and serum (sbetaCTX), and immunoreactive free deoxypyridinoline (uifDPD) in urine were measured as resorption markers. Procollagen type I N-terminal propeptide (PINP), osteocalcin (OC), and bone alkaline phosphatase (bone ALP) were measured as formation markers. All bone formation and resorption markers were significantly lower in the fed state with the exception of bone ALP. The magnitude of the decrease ranged from 3.8 +/- 0.9% for PINP (p < 0.0001) to 17.8 +/- 2.6% (p < 0.0001) for sbetaCTX. Measurement variability was partitioned into analytical variability based on replicate assays (CV(a)) and within-subject variability (CV(i)). The CV(i) was greater (p < 0.05) for some markers in the fasting state (uifDPD, uNTX, and sNTX) but greater in the fed state for other markers (OC and sbetaCTX). In conclusion, the clinical impact of feeding vs. fasting is small with the exception of sbetaCTX; however, in clinical practice, collection of samples in the fasting state may be necessary to minimize the unpredictable effects of feeding. The mechanism of the acute effect of feeding on bone turnover remains uncertain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12052458     DOI: 10.1016/s8756-3282(02)00728-7

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  78 in total

Review 1.  The hunger games of skeletal metabolism.

Authors:  Natalie K Y Wee; Paul A Baldock
Journal:  Bonekey Rep       Date:  2014-11-12

Review 2.  Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?

Authors:  J J Stepan
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

Review 3.  Bone turnover markers: use in osteoporosis.

Authors:  Kim Naylor; Richard Eastell
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

Review 4.  Bone remodeling markers: assessment of fracture risk and fracture risk reduction.

Authors:  Aubrey Blumsohn
Journal:  Curr Osteoporos Rep       Date:  2003-12       Impact factor: 5.096

5.  Prediction of bone loss using biochemical markers of bone turnover.

Authors:  J Lenora; K K Ivaska; K J Obrant; P Gerdhem
Journal:  Osteoporos Int       Date:  2007-04-18       Impact factor: 4.507

Review 6.  Relationships between fat and bone.

Authors:  I R Reid
Journal:  Osteoporos Int       Date:  2007-10-27       Impact factor: 4.507

7.  Breaking into bone biology: serotonin's secrets.

Authors:  Clifford J Rosen
Journal:  Nat Med       Date:  2009-02       Impact factor: 53.440

Review 8.  Influence of hormonal appetite and energy regulators on bone.

Authors:  Ee Cheng Khor; Natalie Kah Yun Wee; Paul A Baldock
Journal:  Curr Osteoporos Rep       Date:  2013-09       Impact factor: 5.096

9.  The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women.

Authors:  Elma Kučukalić-Selimović; Amina Valjevac; Almira Hadžović-Džuvo
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

Review 10.  Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.

Authors:  Matthew B Greenblatt; Joy N Tsai; Marc N Wein
Journal:  Clin Chem       Date:  2016-12-09       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.